Latest News - HCA Healthcare
Top Corporates Hub
HCA Healthcare
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496
07.10.2026 09:52
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.
1 Unpopular Stock That Deserves a Second Chance and 2 We Question
05.10.2026 10:43
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Can HCA Healthcare (HCA) Overcome Healthcare’s Margin Pressures?
29.09.2026 01:07
On September 22, BMO Capital analyst Sean Dodge initiated coverage of HCA Healthcare, Inc. (NYSE:HCA) with an Outperform rating and a $495 price target. The bullish initiation centers on HCA’s targeted capital investments in high-growth geographic markets backed by strong demographic tailwinds. Coupled with compounding efficiency gains from its ongoing “resiliency” program and digital transformation, […]
Can HCA Healthcare (HCA) Overcome Healthcare’s Margin Pressures?
29.09.2026 01:07
On September 22, BMO Capital analyst Sean Dodge initiated coverage of HCA Healthcare, Inc. (NYSE:HCA) with an Outperform rating and a $495 price target. The bullish initiation centers on HCA’s targeted capital investments in high-growth geographic markets backed by strong demographic tailwinds. Coupled with compounding efficiency gains from its ongoing “resiliency” program and digital transformation, […]
Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
28.09.2026 12:50
HCA's rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently.
Can Community Health Sustain Growth as Elective Demand Softens?
25.09.2026 12:27
CYH's volume growth faces pressure from softer elective procedures and payer mix, while a recovery in demand could help margins and cash flow.
Nutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)
24.09.2026 01:32
Nutex Health's profitability and growth metrics significantly outpace peers, driven by effective use of the No Surprises Act and disciplined cost controls. See why NUTX stock is a Buy.
HCA Healthcare (HCA) Shares Moved, What Is Driving Attention Today?
23.09.2026 13:17
HCA Healthcare (HCA) is back in focus after five affiliated Texas hospitals filed suit against Independence Blue Cross, alleging more than $345,000 in unpaid claims between 2022 and 2024. At a share price of US$438.12, HCA Healthcare has seen a 2.85% 1 day share price return and a 12.99% 90 day share price return. Total shareholder return of 7.73% over one year and 80.41% over three years points to momentum that has built over time, even as the year to date share price return is down 6.86%,...
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
23.09.2026 07:49
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495
23.09.2026 05:32
BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform rating and announces Price Target of $495.
HCA Healthcare Sees Solid Demand as Exchange Headwinds Pressure 2026 Outlook
18.09.2026 03:02
HCA Healthcare (NYSE:HCA) CFO Mike Marks said the hospital operator is navigating a changing policy environment in 2026 while continuing to see solid underlying demand for services outside of the health insurance exchanges. Speaking at an investor conference, Marks described the expiration of enhan
HCA Healthcare Completes Acquisition of the College of Health Care Professions
15.09.2026 12:30
NASHVILLE, Tenn., September 15, 2026--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has completed the previously announced acquisition of The College of Health Care Professions (CHCP).
RoundTable Healthcare Partners Appoints Ed Jones as Operating Partner
15.09.2026 12:28
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that Ed Jones has joined the firm as an Operating Partner.
Uncover the latest developments among S&P500 stocks in today's session.
09.09.2026 19:05
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
09.09.2026 12:47
HCA Healthcare CEO Says Guidance For Balance Of Year Does Not Assume A Rebound In Surgery
09.09.2026 10:32
- conference call
Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?
04.09.2026 15:30
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine
02.09.2026 13:00
BRENTWOOD, Tenn. & TYLER, Texas, September 02, 2026--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler – the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women's health, pulmonary, ortho
Tenet to Participate in the Wells Fargo Healthcare Conference
02.09.2026 13:00
DALLAS, September 02, 2026--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, beginning at 12:45 p.m. Eastern Time.
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
02.09.2026 11:30
LONDON & NEW YORK, September 02, 2026--Compass Pathways, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, has been named a 2026 Fierce 50 Breakthrough honoree by Fierce Pharma, Fierce Biotech and Fierce Healthcare. The Fierce 50 recognizes 50 individuals and organizations driving advancements in medicine, fostering innovation and shaping the future of biopharma and healthcare.